LSE:BXP

Beximco Pharmaceuticals Limited · LSE · Healthcare · GBP · FY for 2024

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aGBp

Market data

7.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed
- Computed from the filing for 2024
12.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
13.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
13.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
0.13Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Five bars, one line

lens 7 of 9

1.70x

1.64x

4.94x

0.70x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2024

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2024

Sales1.70x
Its own average over 10 years, 26.08B.
Profit1.64x
Its own average over 10 years, 3.55B.
Free cash flow4.94x
Its own average over 10 years, 1.24B.
Debt0.70x
Its own average over 10 years, 8.65B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 4.94 times.

Sales is 1.70 times its own 10-year average; Profit is 1.64 times its own 10-year average; Free cash flow is 4.94 times its own 10-year average; Debt is 0.70 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

Sales against its own 10-year average1.70
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Profit against its own 10-year average1.64
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Free cash flow against its own 10-year average4.94
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Debt against its own 10-year average0.70
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
GBp